Director, New Products Strategy and Innovation
Ipsen
About this role
Ipsen is seeking a Director of New Products Strategy and Innovation to lead strategic evaluations, business development, and early commercial planning in oncology, rare diseases, and neuroscience. The role involves collaborating with cross-functional teams, supporting pipeline growth, and advancing company strategy in a global biopharmaceutical context.
Skills
About Ipsen
ipsen.comIpsen is a global biopharmaceutical company focused on innovation and specialty care to improve the lives of patients around the world.
Recent company news
BioSpaceIpsen appoints Michelle C. Werner as EVP, President of North America
5 hours ago
pharmaphorumIpsen appoints Michelle Werner as North America head
3 hours ago
The Pharma LetterMichelle Werner to head up North American ops for Ipsen
3 hours ago
MarketBeatIPSEN (OTCMKTS:IPSEY) Stock Crosses Above Two Hundred Day Moving Average - Here's What Happened
9 hours ago
Fierce PharmaIpsen backs away from cancer med Tazverik after safety signals emerge in lymphoma trial
3 days ago
About Ipsen
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Leadership Team
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
Unlock Company Insights
View leadership team, funding history,
and employee contacts for Ipsen.
Salary
$139k – $186k
per year
More jobs at Ipsen
Similar Jobs
Senior Director Commercial Planning & Strategy, Global Rare Disease & Cardio-metabolic
Regeneron Pharmaceuticals
Executive Director, Disease Area Strategy Lead, Obesity and Related Conditions
Amgen
Associate Commercial Strategy & Planning Director (New Product Planning)
Exelixis
Director, New Product Planning & Drug Delivery Innovation
Gilead Sciences
US Tech Consultant / Senior Consultant - Insights and Analytics
Blue Matter
Director, New Product Commercialization
Neurocrine Biosciences